Raymond James & Associates’s Sylvamo SLVM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$1.3M Buy
15,097
+8,060
+115% +$602K ﹤0.01% 2513
2024
Q2
$483K Buy
7,037
+2,566
+57% +$169K ﹤0.01% 3101
2024
Q1
$276K Sell
4,471
-360
-7% -$19.2K ﹤0.01% 3413
2023
Q4
$237K Sell
4,831
-862
-15% -$40.3K ﹤0.01% 3420
2023
Q3
$250K Sell
5,693
-5,438
-49% -$234K ﹤0.01% 3329
2023
Q2
$450K Buy
11,131
+607
+6% +$26.2K ﹤0.01% 3006
2023
Q1
$487K Buy
10,524
+1,599
+18% +$75.9K ﹤0.01% 2934
2022
Q4
$434K Sell
8,925
-401
-4% -$19.2K ﹤0.01% 2992
2022
Q3
$316K Sell
9,326
-2,924
-24% -$111K ﹤0.01% 3144
2022
Q2
$400K Sell
12,250
-5,052
-29% -$212K ﹤0.01% 3048
2022
Q1
$576K Sell
17,302
-6,610
-28% -$219K ﹤0.01% 2989
2021
Q4
$667K Buy
+23,912
New +$696K ﹤0.01% 2885

Other funds holding SLVM

Raymond James & Associates's SLVM Position: Q3 2024 in Review

Raymond James & Associates increased its Sylvamo (SLVM) stake by 115% in Q3 2024, buying an estimated $602K and bringing the position to 15,097 shares worth $1.3M. The position accounts for ﹤0.01% of the portfolio, ranked #2513.

Raymond James & Associates first reported a position in SLVM in Q4 2021 and has held it in 12 quarters since. 400 funds tracked by Wall St. Rank hold SLVM as of Q3 2024.

  • Raymond James & Associates held 15,097 shares of Sylvamo worth $1.3M as of Q3 2024.
  • Raymond James & Associates bought 8,060 Sylvamo shares in Q3 2024, an estimated $602K.
  • Sylvamo made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #2513 holding.
  • Raymond James & Associates first reported a position in Sylvamo in Q4 2021 and has held it in 12 quarters since.
  • 400 funds tracked by Wall St. Rank held Sylvamo as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.